We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
Revised contract addresses concerns over costly glut of unwanted shots as public health threat wanes
US biotech group is among coronavirus vaccine makers struggling with reduced demand post-pandemic
From India to Britain, we have always managed to get in the way of our own inventiveness
A demonised elite produced vaccines and furloughs while a supposedly rebellious public mostly followed the rules
Noubar Afeyan says court rulings on abortion pills and access to healthcare undermine efforts to combat diseases
European health officials have advocated portfolio diversity to help fight different variants
Covid vaccine maker is sitting on $18bn and embarking on a host of ambitious projects
Revamp that would cut drugmakers’ years of market exclusivity meets fierce opposition from sector
Proposal for compulsory licensing risks ire of pharma groups keen to protect patents and revenue
Expected fall highlights challenges for pharmaceutical companies that experienced pandemic windfall
Central American nation was one of Taipei’s last partners in Washington’s backyard
Four member states including Poland say amended deal is not ‘fair solution’ to surplus of shots
Health secretary confirms acceptance of advice from expert committee to ‘bridge the gap’ to autumn
Pharma group hopes for approval of mRNA vaccine for booster shots
UK biotech racing to keep antibody up to date with latest variants
Hong Kong-based lender seeks to cater to mainlanders’ demand for western jabs
Pharmaceutical groups to part ways with longstanding executives
South Korean vaccine maker looks elsewhere to expand overseas business
Jab developed by CanSinoBio could help nation grappling with a wave of infection
A surge in cases after China lifted restrictions has sparked concerns that a dangerous new strain could emerge
Beijing rejects Brussels’ offer, citing full control of situation
Explosion of cases and ban on more effective western shots lead residents to look abroad
Authorities have relied on vaccines made using original strain found in Wuhan
Joe Biden’s chief medical adviser urges Beijing to approve use of western vaccines
Nearly 90mn Chinese are insufficiently protected against Covid as Beijing begins to unwind pandemic controls
International Edition
